SCHEMBL5589089

SCHEMBL5589089

CCCCCc1c(O)c(O)c(Cl)c(CCCCC)c1CCCCC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.40
ALOX5 P09917 5/20 0.39
TYMP P19971 3/20 0.38
TYR P14679 1/20 0.38
PTGS2 P35354 4/20 0.36
CYP3A4 P08684 2/20 0.36
CFTR P13569 1/20 0.35
ESR1 P03372 2/20 0.35
ADRA2A P08913 2/20 0.35
ADORA3 P0DMS8 2/20 0.35
TACR2 P21452 2/20 0.35
SLC6A2 P23975 2/20 0.35
SLC6A4 P31645 2/20 0.35
SLC6A3 Q01959 2/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
SHBG P04278 1/20 0.35
TP53 P04637 1/20 0.35
HSPD1 P10809 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5587374 0.98 ALOX5 (0.41) CYP19A1ALOX5TYMPTYRPTGS2
SCHEMBL5589430 0.98 ALOX5 (0.41) CYP19A1ALOX5TYMPTYRPTGS2
SCHEMBL5588841 0.98 ALOX5 (0.41) CYP19A1ALOX5TYMPTYRPTGS2
SCHEMBL5586782 0.98 ALOX5 (0.41) CYP19A1ALOX5TYMPTYRPTGS2
SCHEMBL5589715 0.98 ALOX5 (0.41) CYP19A1ALOX5TYMPTYRPTGS2
SCHEMBL5586631 0.94 HPGD (0.41) CYP19A1ALOX5TYMPTYRCFTR
SCHEMBL5588585 0.92 ALOX5 (0.39) CYP19A1ALOX5TYMPTYRPTGS2
SCHEMBL5588005 0.90 ALOX5 (0.41) ALOX5TYMPTYRPTGS2CYP3A4
SCHEMBL5589386 0.90 ALOX5 (0.41) ALOX5TYMPTYRPTGS2CYP3A4
SCHEMBL5590166 0.90 ALOX5 (0.41) ALOX5TYMPTYRPTGS2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 CYP19A1 1837/4885ALOX5 188/4885TYMP 3431/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.